Related Experiment Video
Updated: Jul 13, 2026

An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause
Published on: August 13, 2019
[Hypertension in postmenopausal women --selected pathomechanisms]
Aneta Pośnik-Urbańska1, Kalina Kawecka-Jaszcz
1I Klinika Kardiologii i Nadciśnienia Tetniczego, Collegium Medicum, Uniwersytet Jagielloński, Kraków.
Insights
Postmenopausal hypertension involves complex factors beyond decreased estrogen, including sympathetic nervous system activation and metabolic changes. Further research is needed to understand these contributing mechanisms for cardiovascular health.
Area of Science:
- Cardiovascular Medicine
- Endocrinology
- Gerontology
Context:
- Arterial hypertension is a significant risk factor for cardiovascular diseases.
- Postmenopausal women experience increased blood pressure, a phenomenon with complex underlying mechanisms.
Purpose:
- To review the multifaceted factors contributing to postmenopausal hypertension.
- To explore the role of decreased estrogen and other physiological changes in hypertension development after menopause.
Summary:
- Estrogen decline is a key factor, but hormone replacement therapy shows limited impact on blood pressure.
- Other contributing factors include sympathetic nervous system activation, renin-angiotensin-aldosterone system, endothelial dysfunction, oxidative stress, and metabolic disorders like dyslipidemia, obesity, and diabetes.
- Insulin resistance and hyperinsulinemia may link metabolic disorders with autonomic dysfunction in postmenopausal hypertension.
Impact:
- Highlights the complex etiology of postmenopausal hypertension, extending beyond estrogen deficiency.
- Underscores the need for comprehensive management strategies addressing multiple risk factors.
- Identifies areas for future experimental and clinical research to elucidate specific mechanisms and improve patient outcomes.
Abstract:
Arterial hypertension is one of the major coronary risk factors for cardiovascular diseases. In women after menopause blood pressure is increased. The mechanisms responsible for the postmenopausal increase in blood pressure are complex and various factors may have some influence on it. A key-role in etiology of postmenopausal hypertension plays a decrease of estrogen production. Hormone replacement therapy in postmenopausal women does not effect significantly blood pressure values. This suggests that the lower level of estrogens is not only one factor in the etiology of hypertension in women in this period. Various elements have been proposed to play a role in etiology of postmenopausal hypertension, such as activation of the sympathetic nervous system, activation of the renin-angiotensin-aldosterone system, endothelium dysfunction, increase in endothelin and oxidative stress, and more common presence of other risk factors for cardiovascular diseases. These include: dyslipidemia, obesity, glucose intolerance and diabetes mellitus type 2, which are correlated with increased risk of cardiovascular complications of arterial hypertension. It is believed that insulin resistance and hyper-insu-linemia provide a link between these disorders and autonomic dysfunction. Many experimental and clinical studies will be necessary to evaluate the importance of the variety of mechanisms described in this review.
Related Concept Videos
Hypertension II: Pathophysiology
Hypertension and Regulation of Blood Pressure
Factors affecting Blood pressure
Physiological Factors:
Menopause
Hormonal Regulation
Hypertension III: Clinical Manifestations and Diagnostic Studies